MS
ORTX

Maven Securities’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Maven Securities’s Portfolio ORTX Stock Details ORTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,093
Closed -$127K – 437
2019
Q3 		$127K Buy
1,093
+25
+2% +$3.49K 0.04% 188
2019
Q2 		$144K Buy
+1,068
New +$188K 0.1% 77

Other funds holding ORTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Maven Securities's ORTX Position: Q4 2019 in Review

Maven Securities sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q4 2019, closing a stake of 1,093 shares — an estimated $127K sold.

Maven Securities first reported a position in ORTX in Q2 2019 and held it in 2 quarters. The position peaked at $144K in Q2 2019. 81 funds tracked by Wall St. Rank hold ORTX as of Q4 2019.

  • Maven Securities reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q4 2019 after selling out during the quarter.
  • Maven Securities sold 1,093 Orchard Therapeutics plc American Depositary Shares shares in Q4 2019, an estimated $127K.
  • Maven Securities first reported a position in Orchard Therapeutics plc American Depositary Shares in Q2 2019 and held it in 2 quarters.
  • Maven Securities's Orchard Therapeutics plc American Depositary Shares position peaked at $144K in Q2 2019.
  • 81 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q4 2019.

Based on Maven Securities's 13F filing for Q4 2019, filed 14 Feb 2020.